📊 台股資料庫

月營收 · 2026-07 · 共 1,979 家

最近更新:11-01 14:13

排序:1.當月營收↓ — 點欄位 ▲▼ 可疊加多欄(數字=優先序)

清除
股票當月營收(億)▲▼MoM▲▼YoY▲▼公布日期▲▼備註
8.52+9.45%+16.58%8/9
8.51-0.75%+52.80%8/11主係北美休閒車輛客戶新產品出貨所致
8.47+1.44%-6.06%8/7自結數尚未經會計師簽證,特此說明。
8.44+13.05%+11.55%8/10
8.43-5.60%+18.28%8/11一一五年六月因佳醫創照健康股份有限公司及其子公司成為合併個體,使本月營收增加75,606仟元及本年累計營收增加151,082仟元。
8.43+9.66%+64.90%8/6本年度營收新增浙江榆陽電子股份有限公司營收
8.42-15.93%-21.76%8/11
8.41+2.36%-7.67%8/11
8.41-3.12%-7.88%8/10
8.39+12.79%+10.01%8/7
8.38-39.80%+6.55%8/11
8.37+79.52%+165.60%8/9配合客戶出貨
8.35-6.73%+15.28%8/7
8.33+13.23%+40.90%8/11
8.25+10.00%+23.11%8/10
8.25-7.08%+32.13%8/10
8.14-5.45%+32.65%8/7
8.13-15.87%+22.35%8/10
8.11-12.00%-10.25%8/8
8.06+4.45%+10.39%8/10
8.00-3.41%+11.02%8/11
7.97+68.36%+51.14%8/11因本期較去年同期驗收案件多,故營業額增加。
7.97-13.47%-3.84%8/7
7.96+114.49%+63.85%8/11主係合併子公司營收陸續於本年度出貨
7.96-94.92%-94.41%8/13當月較去年同期減少主係子公司人壽分離帳戶保險商品資產淨損益減少所致。
7.95-7.74%+2.95%8/10無
7.93-0.25%+4.71%8/10
7.93+25.64%+42.40%8/9
7.92+5.43%+59.79%8/11係因本公司與其他藥廠簽訂藥物經銷代理合約,取得台灣市場多數醫療機構通路之行銷推廣權利所致
7.92+36.31%+50.23%8/11本期營收較高主係新產品量產出貨所致
7.92+0.95%+19.07%8/10
7.89+4.09%-0.33%8/7
7.87+7.11%+8.41%8/10
7.83-9.68%-37.99%8/8
7.81+13.12%+25.70%8/8
7.77+3.61%+7.42%8/8
7.63+22.54%+63.24%8/9客戶需求增加,致使銷貨收入增加
7.62+64.84%+89.96%8/9係因建設部門本期出售房地所致。
7.59+19.24%+0.16%8/10
7.52+10.53%+74.54%8/9客戶需求強勁
7.47+4.13%+7.43%8/7
7.46+1.59%+37.58%8/10
7.46+2.98%+17.41%8/2
7.46+9.28%+11.91%8/7
7.45+6.71%+32.06%8/11
7.40+5.53%+42.51%8/5
7.36+14.06%-10.44%8/10
7.30+12.85%+66.35%8/87月份出貨較去年同期增加所致
7.30+7.33%+102.55%8/7本月增減百分比或本年增減百分比達50%以上:主要係市場需求增加所致。
7.30-0.86%+19.53%8/7
7.28+1.08%+2.25%8/11
7.25-0.11%+13.17%8/11
7.23-18.84%+5.15%8/7
7.19+24.50%+2.71%8/10
7.18+19.11%+19.15%8/6
7.18+1461.90%+316264.75%8/9因建案完工入帳時間差異,本月營業收入及累計營業收入較去年同期產生較大波動。
7.17-12.55%-5.07%8/10
7.09+4.23%+11.87%8/10
7.07-2.83%-7.43%8/10
7.04+1.10%-1.77%8/11
7.00-1.89%+3.42%8/10
7.00+0.76%+9.03%8/6
6.98-0.87%+30.84%8/8
6.95+2.63%+102.03%8/11主因子公司營收上升,致本年度營收較去年同期增加。
6.89+102.15%+266.00%8/9配合客戶出貨
6.88+4.21%+18.50%8/11
6.87-2.42%+2.00%8/7
6.83+1.33%+46.18%8/8
6.82-8.89%+4.48%8/6
6.76+278.72%+23.76%8/6
6.72-37.73%+8.37%8/11
6.72-15.79%-37.40%8/7
6.70+107.04%+187.03%8/7115年7月超高壓線及其相關附屬器材與高壓線出貨量較去年同期增加。
6.70+4.57%+19.54%8/7
6.70+0.91%+3.52%8/11
6.69+17.42%-14.51%8/10
6.66-9.34%+1.21%8/9
6.66-14.24%+12.83%8/7
6.65+16.01%+90.82%8/8航太與國防領域高毛利聚醯亞胺(PI)材料需求成長、漲價效應及高速訂單增加
6.65+37.51%+57.06%8/11本月營收較去年同期增加57.06%,主要係今年接單動能回溫,帶動出貨及營收認列增加所致。
6.65-30.17%-3.84%8/5
6.63+30.43%+15.32%8/10
6.63+6.70%+12.31%8/11
6.61-43.96%-15.81%8/7
6.61+5.89%+47.48%8/10
6.59-14.96%+0.48%8/11
6.58+9.76%+92.98%8/11受市場供需影響。
6.56-16.69%+6.31%8/9
6.55+49.60%+63.19%8/10伺服器用的記憶體模組板訂單量增加。
6.50-13.22%+11.93%8/8
6.48+4.44%+30.57%8/11
6.47+3.85%-2.15%8/11
6.45+0.92%+2.87%8/11無
6.43-1.90%-12.74%8/8
6.42+4.83%+8.76%8/7
6.42-2.80%+0.76%8/9
6.42+1.69%+34.21%8/11
6.40+23.18%+24.65%8/8
6.39-6.19%-16.02%8/7
6.39-28.05%+75.30%8/11本年營收增加主係本年新樓盤交房增加所致。

來源:MOPS 每月營收彙總表 t21sc03;公布日期為 FinMind create_time(逐步回填,「—」表示尚未取得)。